Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Mayo Clinic
European Organisation for Research and Treatment of Cancer - EORTC
Sun Yat-sen University
Hoffmann-La Roche
Jonsson Comprehensive Cancer Center
Tokyo Medical and Dental University
Sun Yat-sen University
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Vaccinogen Inc
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University Hospital, Lille
Philogen S.p.A.
Norwegian Department of Health and Social Affairs
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
The Hospital of Vestfold
AstraZeneca
Fudan University